{"id":19309,"date":"2025-06-01T16:17:39","date_gmt":"2025-06-01T15:17:39","guid":{"rendered":"https:\/\/drugprevent.org.uk\/ppp\/?p=19309"},"modified":"2025-06-01T16:17:39","modified_gmt":"2025-06-01T15:17:39","slug":"how-ai-is-transforming-drug-prevention-and-healthcare-worldwide","status":"publish","type":"post","link":"https:\/\/drugprevent.org.uk\/ppp\/2025\/06\/how-ai-is-transforming-drug-prevention-and-healthcare-worldwide\/","title":{"rendered":"How AI is Transforming Drug Prevention and Healthcare Worldwide"},"content":{"rendered":"<header class=\"article-header entry-header article-header--post\">\n<div class=\"article-header__data\">\n<h1 class=\"entry-title article-header__single-title\"><span style=\"font-size: 14pt; color: #ff6600;\">Opening comment by NDPA: Although this item is a fairly unashamed promo for AI, it nevertheless gives a useful summary of how AI can be applied to this field, so we have retained it.<\/span><\/h1>\n<p class=\"byline entry-meta vcard\"><time class=\"updated entry-time\" datetime=\"2025-05-25\">by Dianova &#8211; 25\/05\/2025<\/time><\/p>\n<\/div>\n<\/header>\n<section class=\"entry-content cf entry-reset\">\n<div class=\"entradilla\">\n<p>&nbsp;<\/p>\n<\/div>\n<p><strong>A New Era in Health Begins with Intelligence \u2014 Artificial and Human<\/strong><\/p>\n<p>Artificial Intelligence (AI) is not just a buzzword \u2014 it\u2019s one of the most transformative forces reshaping modern healthcare. From revolutionizing diagnostics and personalizing treatments to advancing drug prevention strategies, AI is enhancing the way we understand, predict, and treat human health. As the world embraces the potential of AI, organizations working in prevention and treatment must also evolve \u2014 strategically and ethically.<\/p>\n<ol>\n<li>\n<h4><strong>Artificial Intelligence in Healthcare: The Global Landscape<\/strong><\/h4>\n<\/li>\n<\/ol>\n<p>AI is redefining care on a global scale. According to the\u00a0European Commission, AI technologies are already supporting physicians, analyzing large datasets in seconds, and optimizing hospital workflows. Countries like the US, UK, Canada, China, and the EU are implementing large-scale AI integration strategies to support digital health systems.<\/p>\n<p>The\u00a0AI Act of the European Union\u00a0is the world\u2019s first legal framework on AI, emphasizing risk-based regulation. For health-focused organizations, this framework ensures safety, transparency, and human oversight in the deployment of AI tools.<\/p>\n<ol start=\"2\">\n<li><strong>AI\u2019s Role in Drug Discovery, Prevention, and Treatment<\/strong><\/li>\n<\/ol>\n<p>AI accelerates drug discovery and improves accuracy in substance use disorder (SUD) diagnosis and treatment planning. According to\u00a0ScienceDirect, machine learning models can predict relapse risks, personalize therapy plans, and even detect substance use through digital biomarkers such as speech or behavioral patterns.<\/p>\n<p>As\u00a0Gubra\u00a0outlines, AI is enabling:<\/p>\n<ul>\n<li>Simulation of molecular interactions to discover new therapeutic targets<\/li>\n<li>Automation in toxicology screenings<\/li>\n<li>Integration of patient data for tailored treatment<\/li>\n<\/ul>\n<ol start=\"3\">\n<li>\n<h4><strong>Best Practices in AI-Driven Drug Prevention and Education<\/strong><\/h4>\n<\/li>\n<\/ol>\n<p>From chatbots offering 24\/7 counseling to AI-curated educational content, innovative prevention models are emerging worldwide:<\/p>\n<ul>\n<li><strong>USA<\/strong>: The NIH\u2019s\u00a02025 HHS AI Strategic Plan\u00a0promotes AI for early screening of addiction risks, especially in underserved populations.<\/li>\n<li><strong>Denmark<\/strong>: National efforts combine AI with social data to map out drug-use hotspots and target community outreach.<\/li>\n<li><strong>India &amp; Brazil<\/strong>: AI is integrated into mobile health (mHealth) apps that detect mood changes and alert caregivers, reducing dropout rates in prevention programs.<\/li>\n<\/ul>\n<p>Platforms like\u00a0Listen First by UNODC\u00a0could benefit from AI enhancements to deliver content tailored to emotional tone and local language patterns.<\/p>\n<ol start=\"4\">\n<li>\n<h4><strong>AI and the Prevention of Drug Use and Online Gaming Disorders<\/strong><\/h4>\n<\/li>\n<\/ol>\n<p>One of the most exciting \u2014 and necessary \u2014 frontiers of AI is its application in preventing drug use and behavioral addictions such as online gaming disorder. Emerging research shows how predictive algorithms can identify vulnerable individuals and intervene early.<\/p>\n<p>According to a\u00a02023 article in the American Journal of Preventive Medicine, AI tools are being developed to detect substance use behaviors through digital footprints, social media interactions, and app usage patterns. These tools can flag at-risk youth in real time, prompting early outreach.<\/p>\n<p>The\u00a0Ashdin Foundation\u00a0reports that AI-powered interventions, including conversational agents and real-time behavioral monitoring, are revolutionizing how we approach drug prevention \u2014 making it more personalized, scalable, and responsive.<\/p>\n<p>In Portugal, the\u00a0NOVA University Lisbon project\u00a0is pioneering AI models that track user behavior on gambling platforms to intervene before addiction escalates. This approach is equally relevant for youth struggling with excessive gaming \u2014 an issue increasingly associated with anxiety, depression, and even substance use.<\/p>\n<p>As a\u00a0recent Nature Medicine article\u00a0highlights, AI is becoming a cornerstone in the personalization of behavioral health interventions, offering adaptive content, peer support suggestions, and gamified learning modules.<\/p>\n<p>A\u00a0comprehensive review\u00a0confirms that AI algorithms can be trained to predict not only who is likely to use substances but also who is most likely to benefit from specific prevention programs. Moreover,\u00a0NACADA Kenya\u00a0is investing in AI to power community mapping tools that identify high-risk zones and recommend targeted prevention messaging.<\/p>\n<ol start=\"5\">\n<li>\n<h4><strong>Ethical and Educational Considerations<\/strong><\/h4>\n<\/li>\n<\/ol>\n<p>AI offers vast promise, but not without limitations. As explored in\u00a0BMC Medical Education, there is a growing need to train healthcare professionals and community workers to interpret AI results critically. Meanwhile,\u00a0UMaryland\u00a0highlights challenges around algorithmic bias, data privacy, and accountability.<\/p>\n<\/section>\n<p><span style=\"font-size: 14pt;\"><strong>Source:\u00a0 https:\/\/www.dianova.org\/news\/how-ai-is-transforming-drug-prevention-and-healthcare-worldwide\/<\/strong><\/span><\/p>\n<p>Dianova is a Swiss-based NGO.<\/p>\n<section class=\"entry-content cf entry-reset\">&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<\/section>\n","protected":false},"excerpt":{"rendered":"<p>Opening comment by NDPA: Although this item is a fairly unashamed promo for AI, it nevertheless gives a useful summary of how AI can be applied to this field, so we have retained it. by Dianova &#8211; 25\/05\/2025 &nbsp; A New Era in Health Begins with Intelligence \u2014 Artificial and Human Artificial Intelligence (AI) is [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[17,64,75,40],"tags":[],"class_list":["post-19309","post","type-post","status-publish","format-standard","hentry","category-europe-uk","category-health","category-internet","category-prevention-research"],"_links":{"self":[{"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/posts\/19309","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/comments?post=19309"}],"version-history":[{"count":0,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/posts\/19309\/revisions"}],"wp:attachment":[{"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/media?parent=19309"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/categories?post=19309"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/tags?post=19309"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}